D4DR Polyclonal Antibody

DRD4 encodes the D4 subtype of the dopamine receptor. The D4 subtype is a G-protein coupled receptor which inhibits adenylyl cyclase. It is a target for drugs which treat schizophrenia and Parkinson disease. Mutations in DRD4 have been associated with various behavioral phenotypes, including autonomic nervous system dysfunction, attention deficit/hyperactivity disorder, and the personality trait of novelty seeking. DRD4 contains a polymorphic number (2-10 copies) of tandem 48 nt repeats; the sequence shown contains four repeats.

The D4DR Polyclonal Antibody is a highly specific and sensitive antibody designed for the detection of dopamine receptor D4 (D4DR) protein. This antibody is produced using a polyclonal approach, which ensures a high degree of specificity and sensitivity. The D4DR Polyclonal Antibody is suitable for use in a variety of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The D4DR Polyclonal Antibody is manufactured using high-quality materials and state-of-the-art techniques to ensure consistent and reliable results. This antibody has been extensively validated for its specificity and sensitivity, making it an ideal tool for researchers studying the role of D4DR in various physiological and pathological processes.

The D4DR Polyclonal Antibody is supplied in a convenient format, with a range of sizes available to suit different experimental needs. This antibody is also compatible with a variety of detection systems, including chemiluminescence and fluorescence, allowing for flexible and versatile use in a range of experimental settings.

Overall, the D4DR Polyclonal Antibody is a high-quality and reliable tool for the detection of D4DR protein, offering researchers a valuable resource for investigating the role of this important receptor in various biological processes.